Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells

This publication has 75 references indexed in Scilit:

• Nuclear transcription factor-κB as a target for cancer drug development
  Leukemia, 2002
• NF-κB at the crossroads of life and death
  Nature Immunology, 2002
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• Curcumin Causes the Growth Arrest and Apoptosis of B Cell Lymphoma by Downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53
  Clinical Immunology, 1999
• Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation
  Science, 1999
• The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosis
  Genes & Development, 1999
• Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaiaelliptica
  Chemico-Biological Interactions, 1998
• Sesquiterpene Lactones Specifically Inhibit Activation of NF-κB by Preventing the Degradation of IκB-α and IκB-β
  Journal of Biological Chemistry, 1998
• Tetrandrine Inhibits Signal-Induced NF-κB Activation in Rat Alveolar Macrophages
  Biochemical and Biophysical Research Communications, 1997
• Helenalin, an Anti-Inflammatory Sesquiterpene Lactone from Arnica, Selectively Inhibits Transcription Factor NF-κB
  Biological Chemistry, 1997